A Study to Learn More about How Individuals Process Specific Medications Based on Their Genes in Patients with Gastrointestinal Disorders
Rochester, MN
The purpose of this study is to:
- To evaluate the pharmacogenomic profile (PGx) by genotyping 22 genes, including the CYP2D6 genotype, in patients with functional GI disorders.
- To assess the impact of PGx testing on prescriber patterns in this practice.
- To explore the impact of PGx testing on patient outcomes after an assessment in this practice.